Patients' perspectives of telemedicine appointments for psoriatic arthritis during the COVID-19 pandemic: results of a patient-driven pilot survey.

Patient perspectives Psoriatic arthritis Rheumatology Telemedicine

Journal

BMC rheumatology
ISSN: 2520-1026
Titre abrégé: BMC Rheumatol
Pays: England
ID NLM: 101738571

Informations de publication

Date de publication:
22 Feb 2022
Historique:
received: 25 08 2021
accepted: 26 11 2021
entrez: 22 2 2022
pubmed: 23 2 2022
medline: 23 2 2022
Statut: epublish

Résumé

Over recent years the lack of patient involvement in the design, set-up and implementation of clinical research studies has been well recognised; as such there has been a drive within research communities to increase patient participation. Patient perspectives on telemedicine differ widely, with variation in whether patients feel remote consultations are beneficial. By means of a patient-driven survey, we aimed to formally evaluate patient perspectives on its benefits and pitfalls, focusing on patients with psoriatic arthritis (PsA). An e-survey was developed by two patient representatives on the BritPACT steering committee, with a view to determining unmet needs and the perceived impact on clinical care of virtual consultations amongst patients with PsA. 128 patients responded to the e-survey. 109 patients rated the effectiveness of their telemedicine appointment and, of these, 18% felt their virtual consultation was very/extremely effective compared to an in-clinic consultation and 49% felt it was somewhat/equally as effective; furthermore, 48% (51/107) felt that such virtual consultations would be of benefit to them after the pandemic. 36% of respondents felt their virtual consultation was not as effective as an in-clinic review. Themes identified from open-ended questions included the lack of visual cues, lack of physical examination and effect on rapport and ease of open communication as the main pitfalls of virtual consultations. Patients with well-controlled symptoms appeared more satisfied with remote reviews compared to those with active disease, though on the whole respondents recognised the benefits, such as saving travel time and costs. Those who had an established relationship with their health professional appeared less concerned regarding virtual consultations though a recurring view was that newly diagnosed patients should have in-clinic appointments to build rapport and improve symptom control at an early stage. Overall patients' perspectives on virtual consultations varied widely though patients with well-controlled symptoms and those who had a previously established relationship with their healthcare professionals and well-controlled disease appeared more satisfied with remote reviews.

Sections du résumé

BACKGROUND BACKGROUND
Over recent years the lack of patient involvement in the design, set-up and implementation of clinical research studies has been well recognised; as such there has been a drive within research communities to increase patient participation. Patient perspectives on telemedicine differ widely, with variation in whether patients feel remote consultations are beneficial. By means of a patient-driven survey, we aimed to formally evaluate patient perspectives on its benefits and pitfalls, focusing on patients with psoriatic arthritis (PsA).
METHODS METHODS
An e-survey was developed by two patient representatives on the BritPACT steering committee, with a view to determining unmet needs and the perceived impact on clinical care of virtual consultations amongst patients with PsA.
RESULTS RESULTS
128 patients responded to the e-survey. 109 patients rated the effectiveness of their telemedicine appointment and, of these, 18% felt their virtual consultation was very/extremely effective compared to an in-clinic consultation and 49% felt it was somewhat/equally as effective; furthermore, 48% (51/107) felt that such virtual consultations would be of benefit to them after the pandemic. 36% of respondents felt their virtual consultation was not as effective as an in-clinic review. Themes identified from open-ended questions included the lack of visual cues, lack of physical examination and effect on rapport and ease of open communication as the main pitfalls of virtual consultations. Patients with well-controlled symptoms appeared more satisfied with remote reviews compared to those with active disease, though on the whole respondents recognised the benefits, such as saving travel time and costs. Those who had an established relationship with their health professional appeared less concerned regarding virtual consultations though a recurring view was that newly diagnosed patients should have in-clinic appointments to build rapport and improve symptom control at an early stage.
CONCLUSIONS CONCLUSIONS
Overall patients' perspectives on virtual consultations varied widely though patients with well-controlled symptoms and those who had a previously established relationship with their healthcare professionals and well-controlled disease appeared more satisfied with remote reviews.

Identifiants

pubmed: 35189975
doi: 10.1186/s41927-021-00242-y
pii: 10.1186/s41927-021-00242-y
pmc: PMC8860501
doi:

Types de publication

Journal Article

Langues

eng

Pagination

13

Informations de copyright

© 2022. The Author(s).

Références

Arthritis Care Res (Hoboken). 2017 Oct;69(10):1546-1557
pubmed: 27863164
Clin Med (Lond). 2021 Jan;21(1):e94-e95
pubmed: 33479085
Clin Med (Lond). 2020 May 5;20(3):256-261
pubmed: 32371418
Reumatologia. 2021;59(2):73-84
pubmed: 33976460
Clin Rheumatol. 2020 Nov;39(11):3191-3193
pubmed: 32803570
Curr Opin Rheumatol. 2021 May 1;33(3):262-269
pubmed: 33741808
J Telemed Telecare. 2005;11(2):60-70
pubmed: 15829049
Rheumatol Adv Pract. 2020 Dec 14;5(1):rkaa072
pubmed: 33604501

Auteurs

Hannah Jethwa (H)

Department of Rheumatology, Hammersmith Hospital, 72 Du Cane Road, London, W12 0HS, UK. hannahjethwa@nhs.net.

Emma Dures (E)

Academic Rheumatology, Bristol Royal Infirmary and Centre for Healthcare and Clinical Research, University of West of England, Bristol, UK.

Nicola J Gullick (NJ)

Department of Rheumatology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

Classifications MeSH